Telix: A masterclass in what this game is all about

Today's market darling reminds us why we love to invest. But is it too late?

| More on:
A boy is excited because he won the computer game.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Every now and again, an ASX company emerges that captures the hearts and minds of investors. 

It doesn't happen every year, but it certainly happens more often than you think. 

From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to Supply Network (ASX: SNL), these companies have all produced total returns in excess of 700% over the last 5 years. 

The latest market darling is, of course, none other than Telix Pharmaceuticals (ASX: TLX). 

Just 5 years ago, the company reported revenue of $3.5m and now its 2025 sales guidance is in excess of $1.2 billion (US$785m at the midpoint), a phenomenal 343x increase! 

Its share price has done alright, just a lazy 25x increase over the same period. 

It's the stuff that dreams are made of, and it reminds us why we love this game of investing. 

Now, if you cut out the hype, there are actually important investing lessons to learn from Telix.

Stay optimistic and always look forward 

Five years ago, we were in the midst of a pandemic, and the world was facing a lot of uncertainty. (Not much has changed!). 

It would have been easy to ignore a small, speculative pharmaceutical company with $3.5m in revenue, but investing is all about looking ahead, imagining all the different possibilities, and pricing them accordingly. 

No matter what the headlines say, the share market will surprise you with the opportunities that it can create. Stay optimistic, always look forward. 

Business fundamentals matter

A 25x share price return is nice, but the real story here is the 343x increase in sales. Students of the game know how important it is to study the business and its fundamentals. 

The context matters too. Sales growth may be important for Telix now as a growth company, but perhaps at some point in the future, earnings per share and free cash flow will become more important metrics. 

Tough times will come 

Sorry to be the bearer of bad news, but tough times will eventually come. At some point, Telix shareholders will have to deal with a major share price decline. It could be up to a 20% decline, or it could be a lot more. 

It happens to every market darling, and it's just the nature of the beast. 

The time to mentally prepare yourself and work out what you would do in such a scenario is now. Write down your game plan, explain your rationale, and constantly re-evaluate it using the business fundamentals as your guide. Tough times will eventually come. 

You don't need a Telix to do well

Telix's monster returns are worth celebrating; this is a company solving real-world problems after all. But let me be clear: you don't need Telix to do well in the share market. 

I say this because it's natural for investors who have missed out on Telix to have that fear of missing out (FOMO). If that's you, remember that there are plenty of opportunities out there. 

They won't all do as well as Telix, but even a 2x return in 5 years (just short of a 15% compounded annual growth rate) is a great return. 

Find the next Telix 

Finally, it's of no use to just look back at Telix's success without applying the lessons to help us find the next Telix. Ultimately, finding winning companies is what this game is all about. That's why we love it. 

If you need some help doing that, I know a band of merry Fools who just might be able to help…

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young woman looks at something on her laptop, wondering what will come next.
Opinions

Worried about another stock market sell-off?

Market declines don’t need to be too scary.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the Australian share market today.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an unexpectedly positive session this hump day.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

An evening shot of a busy Times Square in New York.
Opinions

The pros and cons of buying US-focused ASX ETFs in the current environment

In a short amount of time, the US share market has erased the declines that it went through at the…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Aristocrat, EBR, GQG, and Insignia shares are tumbling today

These shares are having a tough time on hump day. Let's find out why.

Read more »

Five businessmen in suits walking up stairs in neat succession.
52-Week Highs

5 ASX 200 shares smashing new 52-week highs today

These five ASX 200 shares just broke into new multi-year and all-time highs. Here’s why.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 21% on 'exceptional' results

Investors are sending the ASX All Ords stock flying higher on Wednesday. But why?

Read more »